Literature DB >> 9048338

Predicting renal outcome in IgA nephropathy.

M G Radford1, J V Donadio, E J Bergstralh, J P Grande.   

Abstract

Immunoglobulin A (IgA) nephropathy, the most common form of glomerulonephritis worldwide, is characterized by a heterogeneous clinical course. In this study, multivariate analysis was performed to identify histopathologic and clinical features that most accurately predict adverse outcome from a dataset of 148 individuals with IgA nephropathy who underwent renal biopsy at our institution between 1973 and 1995. A semiquantitative scoring system was developed for assessment of six glomerular, eight interstitial, and six vascular histopathologic features of IgA nephropathy. Glomerular and interstitial proliferative activity was evaluated by immunostaining archival biopsy specimens with Mib-1, an antibody directed against the Ki-67 antigen. Kaplan-Meier survival analysis was performed, with renal failure being defined as onset of dialysis or transplantation. A number of clinicopathologic factors were univariately associated with adverse outcome, including elevated serum creatinine levels; the presence of hypertension; proteinuria; component and total histopathologic scores; and positive glomerular or interstitial Mib-1 scores. The total glomerular score, consisting of the arithmetic sum of each of the six component scores, was the strongest histopathologic predictor of adverse outcome. Total interstitial and vascular scores also provided more prognostic information than did individual component scores. By multivariate analysis, high total glomerular scores, increased serum creatinine levels at diagnosis, and younger age were significant (P < 0.01) independent predictors of renal failure. Our studies provide a rational basis for the inclusion of composite histopathologic scores in clinical intervention studies of patients with IgA nephropathy and other glomerular disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048338     DOI: 10.1681/ASN.V82199

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  124 in total

1.  Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.

Authors:  Aron Chakera; Clare MacEwen; Shubha S Bellur; La-Or Chompuk; Daniel Lunn; Ian S D Roberts
Journal:  J Nephrol       Date:  2015-08-30       Impact factor: 3.902

2.  IgA nephropathy in association with Crohn's disease.

Authors:  M J Forshaw; O Guirguis; T W Hennigan
Journal:  Int J Colorectal Dis       Date:  2005-01-25       Impact factor: 2.571

3.  CD19+CD5+ B cells in primary IgA nephropathy.

Authors:  He Yuling; Xiao Ruijing; Ji Xiang; Jiang Yanping; Chen Lang; Li Li; Yang Dingping; Tan Xinti; Liu Jingyi; Tang Zhiqing; Bi Yongyi; Xia Bing; Wu Xinxing; Jin Youxin; David A Fox; Steven K Lundy; Ding Guohua; Tan Jinquan
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

4.  Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy.

Authors:  Miho Tatematsu; Yoshinari Yasuda; Yoshiki Morita; Izumi Sakamoto; Kei Kurata; Tomohiko Naruse; Rhohei Yamamoto; Naotake Tsuboi; Waichi Sato; Enyu Imai; Seiichi Matsuo; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2012-05-23       Impact factor: 2.801

Review 5.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

6.  Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Ritsuko Katafuchi; Kosuke Masutani; Akihiro Tsuchimoto; Hideko Noguchi; Hideki Hirakata; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

7.  The use of the Oxford classification of IgA nephropathy to predict renal survival.

Authors:  Eric Alamartine; Catherine Sauron; Blandine Laurent; Aurore Sury; Aline Seffert; Christophe Mariat
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

8.  Study on the relationship between blood stasis syndrome and clinical pathology in 227 patients with primary glomerular disease.

Authors:  Shen Li; Xiang-rong Rao; Su-xia Wang; Gai-hua Zhang; Xiao-mei Li; Xi-wen Dai; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2009-07-02       Impact factor: 1.978

9.  Hyperuricemia is associated with progression of IgA nephropathy.

Authors:  Ali Bakan; Alihan Oral; Omer Celal Elcioglu; Mumtaz Takir; Osman Kostek; Abdullah Ozkok; Semih Basci; Abdullah Sumnu; Savas Ozturk; Murat Sipahioglu; Aydın Turkmen; Luminita Voroneanu; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2015-03-12       Impact factor: 2.370

10.  Glomerular density in renal biopsy specimens predicts the long-term prognosis of IgA nephropathy.

Authors:  Nobuo Tsuboi; Tetsuya Kawamura; Kentaro Koike; Hideo Okonogi; Keita Hirano; Akihiko Hamaguchi; Yoichi Miyazaki; Makoto Ogura; Kensuke Joh; Yasunori Utsunomiya; Tatsuo Hosoya
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.